Intermolecular, Inc. engages in the development of advanced materials using high productivity combinatorial (HPC) technology platform for the semiconductors, consumer electronics, automotive, and aerospace industries worldwide. The company's HPC platform includes Tempus processing tools, automated characterization methods, and informatics analysis software for research and development using combinatorial process systems in concert with established chemical vapor deposition, physical vapor deposition, and atomic layer deposition methods. It serves various markets, including semiconductor, glass, advanced alloys, light-emitting diodes, flat-panel displays, and others. The company was formerly known as The BEP Group, Inc. and changed its name to Intermolecular, Inc. in November 2004. Intermolecular, Inc. was founded in 2004 and is headquartered in San Jose, California.
Industry, Sector and Symbol
Industry Semiconductors & related devices
Sub-IndustrySemiconductors
SectorComputer and Technology
Phone408-582-5700
Debt
Price-To-Earnings
Sales & Book Value
Annual Sales$33.66 million
Profitability
Miscellaneous
Employees105
OptionableNot Optionable
Intermolecular (NASDAQ:IMI) Frequently Asked Questions
What is Intermolecular's stock symbol?
Intermolecular trades on the NASDAQ under the ticker symbol "IMI."
How were Intermolecular's earnings last quarter?
Intermolecular Inc (NASDAQ:IMI) posted its earnings results on Tuesday, February, 12th. The semiconductor company reported ($0.05) EPS for the quarter, hitting the consensus estimate of ($0.05). The semiconductor company had revenue of $6.32 million for the quarter. Intermolecular had a negative return on equity of 9.32% and a negative net margin of 10.13%. View Intermolecular's Earnings History.
When is Intermolecular's next earnings date?
What guidance has Intermolecular issued on next quarter's earnings?
Intermolecular updated its first quarter 2019 earnings guidance on Tuesday, February, 12th. The company provided earnings per share (EPS) guidance of $-0.05--0.04 for the period, compared to the Thomson Reuters consensus estimate of $-0.04. The company issued revenue guidance of $6.1-6.5 million, compared to the consensus revenue estimate of $6.8 million.
What price target have analysts set for IMI?
1 equities research analysts have issued 12-month price objectives for Intermolecular's shares. Their forecasts range from $3.00 to $3.00. On average, they expect Intermolecular's stock price to reach $3.00 in the next year. This suggests a possible upside of 167.9% from the stock's current price. View Analyst Price Targets for Intermolecular.
What is the consensus analysts' recommendation for Intermolecular?
1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Intermolecular in the last year. There are currently 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Intermolecular.
Has Intermolecular been receiving favorable news coverage?
News headlines about IMI stock have trended positive recently, according to InfoTrie Sentiment. InfoTrie identifies negative and positive news coverage by reviewing more than six thousand news and blog sources in real-time. The firm ranks coverage of public companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Intermolecular earned a news impact score of 2.7 on InfoTrie's scale. They also gave press coverage about the semiconductor company a news buzz of 10.0 out of 10, meaning that recent news coverage is extremely likely to have an effect on the company's share price in the next few days.
Who are some of Intermolecular's key competitors?
Some companies that are related to Intermolecular include GSI Technology (GSIT), AXT (AXTI), Adesto Technologies (IOTS), Pixelworks (PXLW), EMCORE (EMKR), Everspin Technologies (MRAM), Kopin (KOPN), POET Technologies (POETF), Resonant (RESN), QuickLogic (QUIK), Sequans Communications (SQNS), ReneSola (SOL), Atomera (ATOM), Netlist (NLST) and LightPath Technologies (LPTH).
Who are Intermolecular's key executives?
Intermolecular's management team includes the folowing people:
- Mr. Christian F. Kramer, Pres, CEO & Director (Age 57)
- Mr. Bill Roeschlein, Sr. VP, CFO & Principal Accounting Officer (Age 49)
- Mr. C. Richard Neely Jr., Consultant (Age 65)
- Mr. Milind Weling, Sr. VP of Programs & Operations
- Dr. Karl Littau, Chief Technology Officer
Who are Intermolecular's major shareholders?
Intermolecular's stock is owned by many different of retail and institutional investors. Top institutional shareholders include Emancipation Management LLC (1.62%), Penbrook Management LLC (0.06%) and Wealthsource Partners LLC (0.06%). Company insiders that own Intermolecular stock include Lloyd I Miller III, Presidio Management Group Ix, and Rick Neely. View Institutional Ownership Trends for Intermolecular.
Which major investors are selling Intermolecular stock?
Which major investors are buying Intermolecular stock?
How do I buy shares of Intermolecular?
Shares of IMI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Intermolecular's stock price today?
One share of IMI stock can currently be purchased for approximately $1.12.
How big of a company is Intermolecular?
Intermolecular has a market capitalization of $55.71 million and generates $33.66 million in revenue each year. Intermolecular employs 105 workers across the globe.
What is Intermolecular's official website?
How can I contact Intermolecular?
Intermolecular's mailing address is 3011 NORTH FIRST STREET, SAN JOSE CA, 95134. The semiconductor company can be reached via phone at 408-582-5700 or via email at [email protected]
MarketBeat Community Rating for Intermolecular (NASDAQ IMI)
MarketBeat's community ratings are surveys of what our community members think about Intermolecular and other stocks. Vote "Outperform" if you believe IMI will outperform the S&P 500 over the long term. Vote "Underperform" if you believe IMI will underperform the S&P 500 over the long term. You may vote once every thirty days.
